Outcomes of Endovascular Therapy versus Microsurgical Treatment for Aneurysmal Subarachnoid Hemorrhage in Patients ≥70 Years of Age
Purpose: This retrospective research aimed to compare the efficacy of endovascular therapy (EVT) versus microsurgical treatment (MST) for elderly patients with aneurysmal subarachnoid hemorrhage (aSAH).Methods: Elderly (>70 years) patients with aSAH who underwent aneurysm obliteration during 2007...
Gespeichert in:
Veröffentlicht in: | Journal of Neuroendovascular Therapy 2020, Vol.14(1), pp.1-7 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng ; jpn |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose: This retrospective research aimed to compare the efficacy of endovascular therapy (EVT) versus microsurgical treatment (MST) for elderly patients with aneurysmal subarachnoid hemorrhage (aSAH).Methods: Elderly (>70 years) patients with aSAH who underwent aneurysm obliteration during 2007–2017 were selected from our hospital database and enrolled in this retrospective study. We reviewed each patient’s background, the severity of the aSAH, and aneurysmal characteristics that compelled EVT or microsurgery treatment and then compared the two treatment groups. A favorable primary outcome was defined by a modified Rankin scale (mRS) score of 0–3 at hospital discharge. The 78 patients formed two cohorts (39 patients each) based on their propensity scores for EVT or MST. We estimated the adjusted odds ratio, followed by a sensitivity analysis of the original 201 patients (118 with EVT and 83 with MST).Results: In the propensity score-matched cohorts, favorable outcomes were observed in 33.3% and 7.7% of patients in the EVT and MST groups, respectively (p = 0.01). Results of the sensitivity analysis were similar to the main results.Conclusion: The clinical outcomes for the elderly aSAH patients were better in the EVT group than in MST group. |
---|---|
ISSN: | 1882-4072 2186-2494 |
DOI: | 10.5797/jnet.oa.2019-0092 |